BioLineRx (BLRX) Non-cash Items (2013 - 2025)

BioLineRx's Non-cash Items history runs 13 years deep, the most recent figure standing at -$964000.0 for Q4 2025.

• On a quarterly basis, Non-cash Items rose 82.22% year-over-year to -$964000.0 in Q4 2025; TTM through Dec 2025 was -$6.0 million, a 82.55% increase from a year earlier, with the FY2025 full-year figure at -$6.0 million, up 82.55% from the prior year.
• Non-cash Items retreated to -$964000.0 in Q4 2025 per BLRX's latest filing, from $228000.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $18.9 million in Q4 2023 and bottomed at -$22.0 million in Q3 2024.
• The 5-year median for Non-cash Items is $107000.0 (2022), against an average of -$25100.0.
• Across the five-year window, Non-cash Items soared 39222.92% in 2023 and sank 503.47% in 2024, its largest moves.
• Year by year, Non-cash Items stood at -$1.2 million in 2021, then surged by 104.0% to $48000.0 in 2022, then surged by 39222.92% to $18.9 million in 2023, then sank by 128.73% to -$5.4 million in 2024, then jumped by 82.22% to -$964000.0 in 2025.
• Per Business Quant, the three latest BLRX Non-cash Items figures stand at -$964000.0 (Q4 2025), $228000.0 (Q3 2025), and $2.4 million (Q2 2025).